Nathalie Ortéga

The IL-1-Like Cytokine IL-33 Is Constitutively Expressed in the Nucleus of Endothelial Cells and Epithelial Cells In Vivo: A Novel ‘Alarmin’?

Christine Moussion, Nathalie Ortéga, Jean‐Philippe Girard · PLoS ONE · 2008 · 1.2K citations · Full text

Life Sciences, Cell Biology, Immunology +17

IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factor <i>in vivo</i>

Virginie Carrière, Lucie Roussel, Nathalie Ortéga et al. · Proceedings of the National Academy of Sciences · 2006 · 949 citations · Full text

Life Sciences, Immunology, Molecular Biology +15

Altered endochondral bone development in matrix metalloproteinase 13-deficient mice

Dominique Stickens, Danielle J. Behonick, Nathalie Ortéga et al. · Development · 2004 · 602 citations · Full text

Medicine, Molecular Genetics, Pathology +17

Endogenous IL-33 Is Highly Expressed in Mouse Epithelial Barrier Tissues, Lymphoid Organs, Brain, Embryos, and Inflamed Tissues: In Situ Analysis Using a Novel <i>Il-33–LacZ</i> Gene Trap Reporter Strain

Mélanie Pichery, Emilie Mirey, Pascale Mercier et al. · The Journal of Immunology · 2012 · 454 citations

Life Sciences, Immunology, Molecular Biology +17

Tumor-associated high endothelial venules mediate lymphocyte entry into tumors and predict response to PD-1 plus CTLA-4 combination immunotherapy

Assia Asrir, Claire Tardiveau, Juliette Coudert et al. · Cancer Cell · 2022 · 251 citations · Full text

Medicine, Immunology, Oncology +17